Focus Diagnostics, a wholly owned subsidiary of Quest Diagnostics. Focus Diagnostics Reference Laboratory is a resource for infectious disease diagnostic testing services and laboratory expertise. We offer over 1200 tests and panels and are continually adding new tests to our menu. Areas of expertise include molecular diagnostics, esoteric microbiology, vaccine response, respiratory, transplant, recipient, gastrointestinal, vector-borne, autoimmune and neuropathy testing. In the area of clinical trials, Focus Diagnostics partners with the major pharmaceutical companies and bioventures involved in the development of vaccines and immune modulators. We are recognized in both the clinical and research communities as an essential resource for infectious disease testing and expertise as a result of our commitment to innovation, quality, and highly personalized service.

Focus has had a long history of developing new and innovative testing services. Our R&D efforts typically result in the development of numerous new and/or improved laboratory assays every year. In its quest to "beat the disease to the market" Focus has served as the initial entry point for many infectious disease tests in the US including, but not limited to Lyme disease, human Parvovirus, Chlamydia pneumoniae, Hantavirus, West Nile Virus, SARS and the H1N1 influenza virus. Today Focus Diagnostics enjoys one of the best reputations in the industry as a market innovator, a provider of exceptional personal service, and a producer of high quality test results. As part of the Quest Diagnostics family, Focus is poised to be an even more vital contributor to the global healthcare community.